PerkinElmer (Filer) Form 424B5: 03/02/2021 1:23 PM: PerkinElmer (Filer) Form 10-K Annual report pursuant to Section 13 or 15(d) 02/16/2021 2:58 PM: Capital Research Global Investors (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/11/2021 1:44 PM: JANUS HENDERSON GROUP PLC (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/08/2021 6:07 PM: PerkinElmer (Issuer)

A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000.

China / 简体中文 Japan / 日本語 India / English United Kingdom / English Germany / Deutsch France / Français South Korea / 한국어 Canada / Français Canada / English Taiwan / 繁體中文 Brazil SEC Filing Keyword Search . Group. Filing date Form Description Filing Group View; 03/30/21: DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") Proxy Filings. 0001193125-21-099191.pdf. 0001193125-21-099191.rtf.

Perkinelmer sec filings

This page shows recent SEC filings related to PerkinElmer, Inc. SEC Accession No. 0001445305-14-000585 PERKINELMER INC (Filer) CIK: 0000031791 (see all company filings) IRS No.: 042052042 | State of Incorp.: The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare from 2011 to 2012 and Philips Healthcare from 2007 to 2011. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, Inc. PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. We provide solutions for the diagnostics, life sciences, food and applied markets. PerkinElmer Inc. all SEC filings breakout by MarketWatch.

PerkinElmer produces analytical instruments, genetic testing and diagnostic on Improving Human and Environmental Health · SEC filings for PerkinElmer, Inc.

Connect with Boston Scientific Investor Relations. Investor relations contact.

a review of United States Securities and Exchange Commission ("SEC") filings Defendant Gregory L. Summe ("Summe") was PerkinElmer's Chief Executive.

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Perkinelmer Inc. PerkinElmer SEC Filings & 10K Form $129.55 +3.70 (+2.94 %) (As of 03/26/2021 04:46 PM ET) Add. Compare. Share . Today's Range. $125.97. Now: $129.55 $129.77.

11 rows 2021-04-09 PerkinElmer (Filer) Form 424B5: 03/02/2021 1:23 PM: PerkinElmer (Filer) Form 10-K Annual report pursuant to Section 13 or 15(d) 02/16/2021 2:58 PM: Capital Research Global Investors (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/11/2021 1:44 PM: JANUS HENDERSON GROUP PLC (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/08/2021 6:07 PM: PerkinElmer (Issuer) Perkinelmer Inc is primarely in the business of laboratory analytical instruments. For financial reporting, their fiscal year ends on December 29th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Perkinelmer Inc. A copy of our Annual Report on Form 10-K for the fiscal year ended December 29, 2019 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000.
False beliefs that cannot be changed by facts

300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 SEC filings for PerkinElmer, Inc. Photographs from the Perkin-Elmer-Applera Collection Science History Institute Digital Collections (Extensive collection of print photographs and slides depicting the staff, facilities, and instrumentation of the Perkin-Elmer Corporation predominately dating from the 1960s and 1970s) PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes due 2031 at an issue price of 99.965% of the principal amount and $400.0 million aggregate principal amount of 3.625% Senior Notes due 2051 at an issue price of 99.999% of the principal PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% 2021-03-04 · PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes Latest SEC filings for PerkinElmer, Inc. (PKI). SEC Form Name Description Date SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K. 1 PerkinElmer (NY: PKI ) 129.88 Quarterly Reports Insider Filings Other Filings.

handelsbanken sparkonto villkor
flyinge plantshop priser
niklas engdahl längd
masterprogram biomedicin uppsala
gymnasielärare jobb stockholm

SEC filings and transcripts for Perkinelmer, Inc., including financials, news, proxies, indentures, prospectuses, and credit agreements

A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018. The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”).

Arocell ab ir
kalciumreglering i kroppen

Perkinelmer Inc is primarely in the business of laboratory analytical instruments. For financial reporting, their fiscal year ends on December 29th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Perkinelmer Inc.

Swedbank Robur Technology Avanza – #SvaraOmISK. N-CSRS. 269 funds culled from biggest Swedish fund platform. Samsta fonderna - SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 Find the latest SEC Filings data for PerkinElmer, Inc. Common Stock (PKI) at Nasdaq.com. PerkinElmer Inc. SEC filings breakout by MarketWatch.

PERKINELMER INC (Filer) CIK: 0000031791 (see all company filings) IRS No.: 042052042 | State of Incorp.:MA | Fiscal Year End: 0102 Type: 10-K | Act: 34 | File No

View the PKI U.S. Securities and Exchange Commission reporting information. SEC filings and transcripts for Perkinelmer, Inc., including financials, news, proxies, indentures, prospectuses, and credit agreements ir@perkinelmer.com (781) 663 - 6900 940 Winter Street Waltham, MA 02451 United States www.perkinelmer.com PerkinElmer Inc. secarticle SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. Recent 13D Filings for PERKINELMER INC (PKI) Since 2020, there have been 14 Schedule 13D forms (beneficial ownership report) filed for the company PERKINELMER INC (stock symbol PKI) by 6 beneficial owners. The information contained in the Company’s filings with SEC, including in the Company’s Form 10-K for the fiscal year ended December 29, 2019 identifies other important factors that could cause actual results to differ materially from those stated in or implied by the forward-looking statements herein.

1 PerkinElmer (NY: PKI ) 129.88 Quarterly Reports Insider Filings Other Filings. Annual Corporate Report. Source: SEC/Edgar. February 25, 2019. 2018 Reports PerkinElmer, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) March 10, 2021 SEC Filings Wed, Mar. 10 Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open SEC Filings Luminex ® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Overview SEC Filing Keyword Search Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing date PerkinElmer Says CEO Prahlad Singh's FY 2020 Total Compensation Was $9.0 Inc Files For Two-Part, Senior Notes Offering Size Not Disclosed - SEC Filing. Stock quote and company snapshot for PERKINELMER INC (PKI), including profile, stock chart, recent news and events, EDGAR SEC Filings – 03/10/2021.